#insight-molecular
Latest news and interesting information about insight-molecular.
BTIG Reiterates Neutral on Insight Molecular Amid FDA Review
BTIG reiterates Neutral rating on Insight Molecular Diagnostics (IMDX) as FDA reviews GraftAssureDx transplant test. Stock up 28% in a week. Revenue surges 116%.
...
